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Coronavirus Overview for Dental Professionals 
Oral health professionals should remain up-to-date on COVID-19 to prevent its 
transmission in the dental practice. 
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This course was published in the April 2020 issue and expires April 2023. The authors have no 
commercial conflicts of interest to disclose. This 2 credit hour self-study activity is electronically 
mediated. 
EDUCATIONAL OBJECTIVES 
After reading this course, the participant should be able to: 
l. Describe the nature of coronaviruses, the types of illnesses they cause, and routes of 
transmission. 
2. Discuss the estimated incubation period for 2079 novel coronavirus (COVID-19), and risk 
factors for various patient populations. 
3. Explain appropriate clinical responses to the COVID-19 pandemic, and what oral health 
professionals can do to prevent its spread in the dental setting. 
INTRODUCTION 
The 2019 novel coronavirus, which manifests as COVID-19, is described as the defining global 
health crisis of our time. The most recent disease to be classified by the World Health 
Organization as a pandemic, COVID-19 joins cholera, bubonic plague, smallpox, and influenza as 
among the most brutal killers in history. As researchers work to develop pharmaceutical 
interventions for COVID-19, valiant efforts are being made worldwide to prevent or reduce 
transmission. Healthcare professionals are facing unprecedented circumstances related to 
patient care and growing concern about this deadly disease; for example, nationwide most 
dental practices are closed except for emergency treatment only. 
This article reviews the emergence, transmission pathways, and symptoms of COVID-19, and 
also provides clinical strategies to help mitigate the pandemic. As an oral health professional 
and educator, I am confident this article will guide dental teams in complying with best 
practices and providing care in accordance with United States Centers for Disease Control and 
Prevention guidelines, ultimately protecting patients, staff, and the community at large. 
-Leann Keefer, ROH, BSEd, MSM 
Director, Clinical Services 
Crosstex International 
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protect patients anastarr ana neIp slow ttie-cuvlu-19 panaemIc 
In late 2079, an outbreak of atypical pneumonia of unknown cause presented in Wuhan in 
China's Hubei Province. Upon investigation, the confirmed cases were linked to a Wuhan 
market where wild animals, including marmots, birds, rabbits, bats, and snakes, were being 
traded illegally. On December 31, 2079, the World Health Organization (WHO) was notified of 
this outbreak by authorities in China. Virological testing disclosed a novel coronavirus in these 
patients, and, within a few weeks, WHO tentatively named it as 2079 novel coronavirus (2079-
2 
nCoV). 
On February 71, 2020, the International Committee on Taxonomy of Viruses announced the new 
3 
name of the virus as severe acute respiratory syndrome coronavirus, or SARS-CoV-2. This was 
chosen due to the virus being genetically related to the coronavirus responsible for the SARS 
3 
outbreak in 2003. On the same day, WHO named the new disease COVID-19, following 
guidelines previously developed with the World Organization for Animal Health and Food and 
3 
Agricultural Organization of the United Nations. Regardless of the nomenclature, this fast-
spreading disease poses a global health risk. Consequently, dental teams should remain up-to­
date on its presentation, and clinical measures to prevent its transmission in the dental setting. 
Coronaviruses (CoV) are a large family of viruses that 
cause illness ranging from respiratory infections 
(including the common cold to flu-like or pneumonia 
symptoms), as well as gastrointestinal symptoms-all 
4 
which may or may not appear and range in severity. 
Middle East respiratory syndrome (MERS-CoV) and 
4 
SARS-CoV outbreaks continue to occur globally. A 
novel coronavirus (nCoV) is a new strain that has not 
been previously identified in humans, and is considered 
a zoonotic disease that spreads from animals to 
humans. Further investigations determined the source 
of SARS-CoV transmission was from civet cats to 
humans and M ERS-CoV from dromedary camels to 
humans. Although the specific source of COVID-19 has 
not been identified, bats and pangolins are currently 
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implicated. As a novel coronavirus, the information scientists have gathered about it may 
5 
change as researchers and the medical community continue to learn how the virus behaves. 
The United States Centers for Disease Control and Prevention (CDC) reinforced the need for 
clinicians to be watchful for exposure to COVID-19, not only with patients who are returning 
travelers from areas with high incidence of the disease, but also with individuals who have 
corn� in q:mtact with th9�� infec;ted. Given the nature of oral h�alth care and disec;ise . h h. This website uses coo"'Ies to improve your experience. We'll assume you're oK wit t Is, 
transmission, dental professionals need to stay abreast of this rapidly evolving public health 




Cases of COVID-19 continue to spread in China and globally. As of April 9, 2020, more than 
1,536,094 cases have been reported worldwide, with 89,877 deaths and more than 340,000 
78 
cases recovering. ' As of April 9, 2020, the United States had more than 395,000 confirmed 
7,9,10 
cases across all 50 states, with 12,754 deaths. 
Chinese officials confirmed the COVID-19 outbreak was associated with the Huanan Seafood 
11 
Market, a "wet market" in Wuhan. Wet markets sell live fish and animals, and have a history of 
transmitting viruses. Typically, purchases are immediately slaughtered on site, which can cause 
particles of infectious bacteria or viruses to become aerosolized and transmit from animals to 
11 
people. Investigators suspect that someone purchased contaminated meat, became sick 
12 
before or after consuming it, and spread the infection to others. Though the virus can spread 
by consuming infected animals, it can also spread through coughing, sneezing, and close 
12 
contact with an infected person or an object carrying the virus. 
According to CDC officials, it may be possible to contract COVID-19 by touching a surface or 
object that has the virus on it and then touching the mouth, nose, or possibly eyes, but this is 
12 
not a confirmed primary mode of transmission. With most respiratory viruses, people are 
12 
typically considered most contagious when they present with acute symptoms. Presently, it is 
not clear how contagious those infected with the virus are during the incubation period; 
however, there have been reports of transmission in individuals who show no signs or 
13 
symptoms of the disease. 
SIGNS, SYMPTOMS, AND PREVENTION 
Signs and symptoms of COVID-19 are similar to other respiratory illnesses, and can include 
runny nose, sore throat, fever, cough, shortness of breath, and breathing difficulties. In more 
advanced cases, infections can lead to pneumonia, severe acute respiratory syndrome, kidney 
4 14 
failure, and death. · Because the symptoms of the coronavirus are similar to that of other 
common respiratory infections (such as a cold or flu), a definitive diagnosis can only be made 
4 ,14 
with a laboratory test. 
15 
The severity of symptoms in confirmed cases has ranged from no or mild symptoms to severe. 
The incubation period-as reported by the CDC at presstime-is between 2 days to 14 days from 
15 
exposure to the occurrence of disease signs and symptoms. By comparison, WHO estimates 
14 
that incubation ranges between l day and 12.5 days, with a median of 5 days to 6 days. The 
estimates for the incubation period for COVID-19 are based on previous observations with other 
14,15 
coronavirus diseases, such as SARS and MERS. 
Th�f:t9�i� �� �itfq ��m�rd€}fl§ft:,icVM§,' l!��crg�Wtl� 11:ih is, 
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complications. At this time, there is no research regarding the susceptibility of pregnant 
10 
women to the virus, and no evidence to suggest children are at increased risk. 
On January 30, 2020, WHO classified the rapidly spreading outbreak as a Public Health 
5,17 
Emergency of International Concern, and on March 11 WHO declared it a pandemic. In 
response to the outbreak, the C DC has partnered with health officials and healthcare systems 
to reduce the impact of the virus and reinforce infection prevention principles. The CDC is using 
a 2077 Morbidity and Mortality Weekly Report as a blueprint for community interventions and 
1819 
adapting it to COVID-19. · With no vaccine available to prevent coronavirus disease, the CDC 
recommends everyday preventive actions to halt the spread of respiratory diseases, including 
20 
COVID-19 {Table 7). 
TABLE 1. Everyday Ac ions to Preven_ the Spread of 
Res-pi ratory Di sea ses20 
• ash your hands often i h soap and a er or a leas 20 seconds, 
especially aft going he b throom, be: or , aUng, and a 
blo Ing our nose, cough·ng, or sneezing. 
I soap and wa er a e no readil� a ailla,bi , us- an akohol-bas d hand 
sa,n� ize, ith a lea 60% akohot Al ays as· hands h soap and 
-,t -r i hands are v 1bly di 
• A oid c ose c,on ·a i people ho are sic . 
• oid ouching our eyes, nose and mou h. 
S a ho · e hen o,u a,e sick. 
Cover you mouth i h a ·ssue h n you sneeze and hro he issue 
·n he rash. 
• Clean ,a1nd d"sin e equen I touched obje s a1nd s rfaces using 
eguiar household cleainmg sprays or ipes. 
• h CO ID� 9, people ho are heal y shoulld ea cloth face 
(O ering hen out in pubHc. 
• People ho sho symp oms ,a COVID-19 should use ace masks o 
help prev nt he spread o· the diiseas _ 
• The se o fac,e ma ks is cru(al or healthcare orke1rs and mdi iduals 
ho, are ta ing ca e of som one m c.lose settings (at home or in ar 
ealthcare acdi l 
RESOURCES FOR CLINICIANS 
Thft, rsD�e�gifJ'(j��?8:?c5RPE!t�8�rl\per5�� �du�eJi*WerfWtiBfu�WJifr�gksutMaJ ti<J4ge& with th is, 
preparedness resources to assist providers, clinics, and hospitals when managing patients with 
potentia I or confi rmle�tca<sel��t§ttµj_ iflY@.!e W�§l:fts if'iOO@e a ��Qr� help identify and 
fter 
t cwt t 
t 
LI 
assess patients who may be ill with, or who may have been exposed to the disease. 
The CDC also offers a clinical criteria form to guide evaluation for individuals under investigation 
22 
for COVID-19 based on what is known about MERS-CoV and SARS-CoV. In the event a person 
under investigation for COVID-19 presents in dental practice, clinicians should immediately 
notify the appropriate infection prevention personnel at their healthcare facility, as well as local 
22 
and state health departments. 
The American Dental Association (ADA) and American Dental Hygienists' Association have 
23 ,24 
issued statements and provided resources related to COVID-19. As of presstime, each 
organization also recommends that oral health professionals postpone elective and 
nonemergency procedures, but remain available for dental emergencies that are considered 
23 24 
"potentially life threatening," according to the ADA. ' Once active practice resumes, it will be 
more important than ever for dental settings to follow standard precautions and infection 
control, as outlined in the CDC's Guidelines for Infection Control in Dental Health-Care Settings 
25 
-2003. 
Oral health professionals who are in contact with patients, and whose responsibilities include 
cleaning and disinfecting, handling contaminated supplies or equipment, and who work in 
proximity to potentially contaminated surfaces, should diligently follow all infection prevention 
20 
procedures. To prevent infections from spreading during healthcare delivery, an effective 
asepsis protocol-including administrative rules, engineering controls, environmental hygiene, 
correct work practices, and appropriate use of personal protective equipment (PPE)-is 
20 
essential. The CDC provides infection control guidance for healthcare settings. These are basic 
rationale and techniques for exposure control, including hand hygiene. Recommendations for 
minimizing exposure to COVID-19 in the dental setting include taking a comprehensive medical 
history, and implementing a facility compliance and prevention plan (Table 2). A recent 
literature review on human and veterinary coronaviruses, including SARS, MERS, and endemic 
human coronaviruses, revealed that each can remain on inanimate surfaces-such as metal, 
glass, or plastic-for up to 9 days. Surface disinfectant protocols with 62% to 71% ethanol 
(rubbing) alcohol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite (bleach) can efficiently 
26 
inactivate the viruses within l minute of contact time. 
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Su. plies: Prov,d supphes or esp·, ory hygiene and coug e ique e, 
in uding 60 o 95% akohol-based and sani izer and ,rssues, as el I as 
no oudi ecep acJes o d1sp saJ 
Us,e ,(au 10n hen P rform'mg Ae,rosol , 1enera(nr1g Procedu1res 0 
• Some procedures erf o,rme on p · ents i h respi1ra ory infe, ions 
could genera _e in e ·ous ae:rosols. 
• Proced_ures ha are U�e:ly to i
1nduce c�ughing (eg, in ol ing use o a 
handp1ece or ul rasomc ms ru en at1on) s_ o Id be pe orm. d 
c.au iousi sing a Le el 3 face mas 
Trai and E · ate ea thcar Per on el2° 
Provide a hcare pe on ne ith job o tas �spec1fk educa ion and 
rain'ng on preven 1ing ransmLsion of infe- ious agen , indudmg 
ref res her rainii g. 
• Ensure tha ealthcare personnel 1re e ucate , ained, a' di a e 
p a ic" d 'the, a prop ia e u e o pe sonial pro e i e eqw pmen (PP ) 
befo,e pro id mg' car . 
• Corif i rm to re use of PP in pre en ion of con am ·1nation o , clo, 
s in and e ·ron . ntduring �e process o r ,o · . s ch equip 
PERSONAL PROTECTIVE EQUIPMENT 
The CDC's Guidelines for Infection Control in Dental Health-Care Settings-2003 discuss the use 
of PPE to prevent potentially infectious splash, spatter, and aerosols generated during rinsing, 
25 
or when using handpieces and other devices (such as ultrasonic units). Employers should 
select appropriate PPE and provide it to oral health professionals in accordance with the 
27 
Occupational Safety and Health Administration's PPE standards (29 CFR 7970 Subpart 7). 
Dental teams must receive training and demonstrate an understanding of when to use PPE; 
what PPE is necessary; how to properly don, use, and doff PPE to prevent self-contamination; 
how to properly dispose of or disinfect and maintain PPE; and the limitations of protective 
28,29 
equipment (Table 3). 
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TABLE 3. P·ersona Ptotectiv,e Equ ipmen 
Gloves 
• Perfo1m : and hyg ene., then pl!lt on clean, non-slier  le glo es p sjo1 o patien, care. Change g lO\tes tf - h ey become torn or hea; ·1 
contam inated. 
• Remove and  dlstard g'lo es ,hen pa ·en tare Is cempleted, and immed iately perfomi hand hygi ne. 
Face Mask P-ro,tec:tion
n 
Level 1 masks provide a protectio n a l ue of � 95% bade ria M ra on  effi ciency ( Bff) and pa rtnu a e ,1,tration e 1de n.cy (f' F E); these a re 
su itable fo.r  rief examiAa ions. ,exposi ng rad i ograplris and dean ing ,tasks. 
level 2 masks offer a modera e protectjon of � 98% BFE and PFE. and are pre •erab!e for ;pr&cetl ·res bat in olve a, moderate 'level o 
aerosols, sudl as ha nd iM rumenta�on os applyi n g  sealan,-s. 
1.t11el 3 masks effie.r a h igh level' of protection of � 98r% BFE a nd PFE, a nd are u sed for proc.edu1es i n o lving h igh I ve� of aeico: e l s, such as 
ultrasonic s,cal ing, su rgical p ocedu tes arid ao n preparat ion. 
Maximum fi ltration masks. such as an, 95 .pertic:u la e respi,rator. feature 99.9% P _ and a re in dicai ed when trea ing pa i ettts wUh 
ai rborne diseases. 
Eye Protection 
• Wear eye protection (eg, safety gtass,es or a disposa le face sh ie d  ha rovers , he front and sides o •he face) upo , enlllJ t nhe  pa,tient 
care a rea 
• Remove e e pro ecHon befo e lea i ng he- patien ca e area. 
• Reu sab e eye protedion (eg, sa e ty g l asses> must be deaned and d isi nfected accord' ng to manu factt1 r-0(s 1ep ocessi ng r n struc'lio ns p - i or 
o reu se. 
• Dispo,sabl'e eye protection. should be discarded afte r se. 
• Den�I lou es must : be dea ed an.d disinfected between each pa ,ienl , o aim· · _cross-contami11,a ion risks. 
Denta l face masks a re a n  i m porta nt physica l ba rr ier  to fl u ids a n d  pa rticu l ate matte r a nd a re 
28 
worn d u ri n g  p roced u res that i nvo lve possi b le  a eroso ls,  sp lash ,  o r  spatter. Accord i n g  to the U S  
Food a nd D r u g  Ad m i n istration ,  a su rg ica l  face mask covers t h e  user 's nose a nd mouth ,  a nd is 
l a beled as a su rg ica l ,  l aser, iso l at ion ,  denta l ,  or m ed ica l p roced u re mask (with or without a face 
30 
sh ie ld ) .  There a re m u lt i p le  l eve ls  of mask protect ion for ora l hea lth professiona ls, each 
identif ied accord i n g  to bacter ia l f i l t ration  a nd pa rticu l ate f i ltrat ion eff ic iency leve ls  that 
28 
correspond to the dema nds of a g iven denta l proced u re. H ea lthca re a nd i nstitut ion a l  setti ngs 
use respi rators that a re at least as p rotective as a f it-tested N atio n a l  I nstitute for Occu pation a l  
Safety a nd H ea lth-certif ied d isposa b le  N95 f i l te r ing  facepiece respi rato r before entry i nto the 
patient ca re a rea . Ora l  hea lth professiona ls worki n g  in  fac i l it ies with h i g h  i nfect ious d isease 
tra nsm iss ion potent ia l ,  such as h ospita ls, l ong-te rm ca re sett ings, a nd denta l  ca re u n its l ocated 
in these type of sett ings, may wa rra nt use of a n  N 95 respi rator. 
SUMMARY 
Al l hea lthca re person ne l  need to be prepa red fo r, a nd rem a i n  i nformed a bout, COVI D-79, its 
ongo ing  status a nd u pd ates, a nd p reventive m easu res to avoid d isease tra nsm iss ion .  Ora l  
hea lth p rofessio n a ls have a respons i b i l ity to be knowl edgea b le  a bout i nfect ious d iseases. 
P�lg���ccil�l2lr��q:lrl:p��e ���r �lt � � tft(e � l?il l'\)fflh th is, 
but you ca n opt-out if you wish .  Accept Rea d M o re 
ff• 
f 
standards of infection control. B y  maintaining a standard of care th at is in accordance with CDC 
guidelines, dental teams can effectively contribute to disease prevention and h elp slow th e 
coronavirus pandemic. 
Recommen dations for M i n i m iz ing Exposure to COVI D-1 9 i n  Denta l Setti ngs20 
Medical History 
Interview 
Prior to Appointment 
Upon Arriva l  
During Appointment 
Oue�ions to Ask Patient 
I 
Recommenci,tions 
• Have you traveled outside of the country or within a geographical a rea that has a h igh 
incidence of COVID-1 9 i n  the last 14 days? 
• Have you been in dose contact with anyone who has traveled outside the cou ntry or 
within a geog raphica l area that has high i ncidences of COVID- 19  i n  the last 1 4  days? 
• Do you have a co ld or any resp i ratory issues? 
• Do you have a fever or have you had a fever within  the last 14 days? 
• Do you have a sore throat? 
• Same questions as above if not ab le to i nterview patient pr ior to the denta l visit 
• If the patient exh ibits signs and symptoms du ri ng care (e.g., resp iratory symptoms, 
coug�, runny nose or feverish), cl i n icians should: 
• I f  "yef/' to any one of these questions, postpone 
patient care 
• Advise patient to seek medi cal attention (if he/she 
has not a l ready done so) 
• I nstruct patient to reschedu le  when free from 
signs/symptoms of a i lment 
• Same as above 
• Stop patient care 
• Advise patient to seek medica l  attention 
• I nstruct patient to reschedu le when free from 
signs/ symptoms of ai lment 
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